| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 01/20/2005 | WO2005004864A1 Benzimidazole derivatives as raf kinase inhibitors |
| 01/20/2005 | WO2005004863A1 Benzimidazole carboxamides as raf kinase inhibitors |
| 01/20/2005 | WO2005004818A2 Heterocyclic compounds and their use as anticancer agents |
| 01/20/2005 | WO2005004810A2 Arylsulfonamide derivatives |
| 01/20/2005 | WO2005004803A2 Phenylcarboxylate beta-secretase inhibitors for the treatment of alzheimer's disease |
| 01/20/2005 | WO2005004801A2 Indole, azaindole and related heterocyclic n-substituted piperazine derivatives |
| 01/20/2005 | WO2005004606A2 Pyridinylanilides |
| 01/20/2005 | WO2004100865A3 New benzimidazole derivatives |
| 01/20/2005 | WO2004096129A3 Inhibitors of akt activity |
| 01/20/2005 | WO2004092166A3 Cgrp receptor antagonists |
| 01/20/2005 | WO2004083208A8 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators |
| 01/20/2005 | WO2004074218A3 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 01/20/2005 | WO2004069793A3 Novel 2-substituted cyclic amines as calcium sensing receptor modulators |
| 01/20/2005 | WO2004069792A3 Quinoline-derived amide modulators of vanilloid vr1 receptor |
| 01/20/2005 | WO2004069158A3 Substituted pyrazoles, compositions containing such compounds and methods of use |
| 01/20/2005 | WO2004026836A3 1-pyridin-4-yl-urea derivatives |
| 01/20/2005 | US20050014942 Transforming growth factor inhibitor; controllign cell differentiation, cell proliferation |
| 01/20/2005 | US20050014939 E.g., N-[4-(2-Pyrrolidinylethoxy)phenyl]-4-oxo-4,5,6,7-tetrahydro-1H-indole-3-carboxamide; treating diseases associated with pathogenic agonism, inverse agonism or antagonism of the GABAA receptor such as anxiety, depression, a sleep disorder, or cognitive impairment |
| 01/20/2005 | US20050014815 Substituted 2-pyrrolidine-2-yl-1H-indole compounds |
| 01/20/2005 | US20050014813 High yield; synthetic pharmaceutical intermediate; diabetes, insulin sensitizers |
| 01/20/2005 | US20050014812 Benzimidazole compounds |
| 01/20/2005 | US20050014811 Such as 4-cyclopentylamino-benzenesulfonic acid 2-(3,4-dimethoxy-phenylamino)-1H-benzoimidazol-5-yl ester; cyclin-dependent kinase inhibitors that are aimed to be more active than flavopiridol |
| 01/20/2005 | US20050014807 Therapeutic compounds for treating dyslipidemic conditions |
| 01/20/2005 | US20050014805 Hypotensive agents; antidiabetic agents; cardiovascular disorders; anticholesterol agents; anticancer agents |
| 01/20/2005 | US20050014795 Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same |
| 01/20/2005 | US20050014793 Pyridinone derivatives for treatment of atherosclerosis |
| 01/20/2005 | US20050014789 Psychological disorderas; antidepressants; obsessive complusive disorders; drug abuse; |
| 01/20/2005 | US20050014788 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5) |
| 01/20/2005 | US20050014786 Tetrahydroquinoline derivatives as cannabinoid receptor modulators |
| 01/20/2005 | US20050014783 Use of Rho-kinase inhibitors in the treatment of aneurysm and cardiac hypertrophy |
| 01/20/2005 | US20050014778 Variolin derivatives as anti-cancer agents |
| 01/20/2005 | US20050014767 Controlling cell proliferative |
| 01/20/2005 | US20050014765 Aryl-heteroaromatic products, compositions comprising them and use |
| 01/20/2005 | US20050014757 Serotonin receptor antagonist; psychological disorders; side effect reduction |
| 01/20/2005 | US20050014753 Antitumor agents |
| 01/20/2005 | US20050014749 Piperazine derivatives and methods of use |
| 01/20/2005 | US20050014746 compounds which bind to the interaction-domain (I-domain) of LFA-1, thus interrupting endothelial cell-leukocyte adhesion by blocking the interaction of LFA-1 with ICAM-1, ICAM-3, and other adhesion molecules |
| 01/20/2005 | US20050014741 2-oxo-benzimidazolyl substituted ethanolamine derivatives and their use as beta3 agonists |
| 01/20/2005 | US20050014650 Delta 1-pyrrolines used as pesticides |
| 01/20/2005 | DE10329860A1 Sulfonamidderivate polycyclischer Farbstoffe für analytische Anwendungen Sulfonamide derivatives of polycyclic dyes for analytical applications |
| 01/20/2005 | DE10329457A1 New 1,2-bis-phenylaminocarbonyl-pyrrolidine derivatives, useful for treating or preventing e.g. thrombosis, myocardial infarct and arteriosclerosis, are inhibitors of coagulation factor Xa |
| 01/20/2005 | DE102004014061A1 Amid-substituierte 1,2,4-Triazin-5(2H)-one Amide substituted 1,2,4-triazine-5 (2H) -ones |
| 01/20/2005 | DE10151695B4 Verfahren zur Herstellung von Imidacloprid Process for the preparation of Imidacloprid |
| 01/20/2005 | CA2532068A1 Pyrrole-2, 5-dithione derivatives as liver x receptor modulators |
| 01/20/2005 | CA2532056A1 Pyrrole-2, 5-dione derivatives as liver x receptor modulators |
| 01/20/2005 | CA2531859A1 Benzimidazole derivatives as raf kinase inhibitors |
| 01/20/2005 | CA2531856A1 Benzimidazole carboxamides as raf kinase inhibitors |
| 01/20/2005 | CA2531751A1 Pyrazolyl-indole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 01/20/2005 | CA2530780A1 Tacrine derivatives as inhibitors of acetylcholinesterase |
| 01/20/2005 | CA2530737A1 Cck-1 receptor modulators |
| 01/20/2005 | CA2530538A1 Thiophenylaminoimidazolines as prostaglandin i2 antagonists |
| 01/20/2005 | CA2530450A1 5-substituted quinazolinone derivatives |
| 01/20/2005 | CA2530312A1 Arylamine-substituted quinazolinone compounds |
| 01/20/2005 | CA2530025A1 17-acetamido-4-azasteroid derivatives as androgen receptor modulators |
| 01/20/2005 | CA2530006A1 Phenylcarboxylate beta-secretase inhibitors for the treatment of alzheimer's disease |
| 01/20/2005 | CA2529739A1 Aspartyl protease inhibitors |
| 01/20/2005 | CA2528626A1 Indoles useful in the treatment of inflammation |
| 01/20/2005 | CA2528336A1 Tetrahydrocarbazole derivatives and their pharmaceutical use |
| 01/19/2005 | EP1498417A1 Heterocyclic amide derivatives |
| 01/19/2005 | EP1498416A1 A process for the optical purification of benzimidazole derivatives |
| 01/19/2005 | EP1498413A1 4-Aminopicolinates and their use as herbicides |
| 01/19/2005 | EP1498411A1 Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient |
| 01/19/2005 | EP1497287A1 Quinolinone derivatives |
| 01/19/2005 | EP1497282A2 Inhibitors of serine protease, particularly hepatitis c virus ns3-ns4 protease |
| 01/19/2005 | EP1497281A2 Azole derivatives as antifungal agents |
| 01/19/2005 | EP1497280A1 Indol-2-ones as selective inhibitors of cyclooxygenase-2 |
| 01/19/2005 | EP1497279A2 Substituted indoles and their use as 5ht-reuptake inhibitors and as 5ht ligands |
| 01/19/2005 | EP1497278A1 Heterocyclic amide derivatives as cytokine inhibitors |
| 01/19/2005 | EP1497269A1 Substituted 2-phenyl-3(2h)-pyridazinones |
| 01/19/2005 | EP1497266A2 Quinoline derivatives and their use as 5-ht6 ligands |
| 01/19/2005 | EP1497265A1 Compounds having affinity at 5ht2c receptor and use thereof in therapy |
| 01/19/2005 | EP1497240A1 Non-heating clay composites for building materials |
| 01/19/2005 | EP1497019A1 Pyrrolo-triazine aniline compounds useful as kinase inhibitors |
| 01/19/2005 | EP1496906A1 Inhibitors of akt activity |
| 01/19/2005 | EP1496900A2 New pharmaceutical compositions based on anticholinergics and p38 kinase inhibitors |
| 01/19/2005 | EP1496896A1 Inhibitors of akt activity |
| 01/19/2005 | EP1496892A2 1h-benzo(f)indazol-5-yl derivatives as selective glucocorticoid receptor modulators |
| 01/19/2005 | EP1496878A1 Methods for identification of modulators of angiogenesis, compounds discovered thereby, and methods of treatment using the compounds |
| 01/19/2005 | EP1496838A2 Substituted amides |
| 01/19/2005 | EP1395574B1 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 01/19/2005 | EP1230244B1 Pyrazolecarboxylic acid tricyclic derivatives, preparation and pharmaceutical compositions containing same |
| 01/19/2005 | CN1568321A Novel substituted 4-phenyl-4-ú¿1h-imidazol-2-ylú®-piperidine derivatives and their use as selective non-peptide delta opioid agonists |
| 01/19/2005 | CN1568313A Piperidine compounds as muscarinic antagonists |
| 01/19/2005 | CN1568207A 2-amino-6-(2, 4, 5-substituted-phenyl)-pyridines |
| 01/19/2005 | CN1568188A Nociceptin analogs |
| 01/19/2005 | CN1568187A 2H-2, 3-dinitrogen phenodiazine-1-ketone and using method thereof |
| 01/19/2005 | CN1568186A Substituted 4-phenyl-4-[1h-imidazol-2-yl]-piperidine derivatives for reducing ischaemic damage |
| 01/19/2005 | CN1568185A Compounds effecting glucokinase |
| 01/19/2005 | CN1566098A Isoquinoline compound, preparation method and application of salt thereof |
| 01/19/2005 | CN1566096A Prostaglandin agonists and their use to treat bonedisorders |
| 01/19/2005 | CN1566091A Molindone derivatives and use for preparing antineoplastic medicine thereof |
| 01/19/2005 | CN1185250C Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 01/19/2005 | CN1185242C Ligand and complex for catalytically bleaching substate |
| 01/19/2005 | CN1185229C 3-indolyl-4-phenyl-1H-pyrrole-2, 5-dione derivatives as inhibitors of glycogen synthase kinase-3beta |
| 01/19/2005 | CN1185228C Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamide derivatives for treatment of pain |
| 01/19/2005 | CN1185227C Novel compounds |
| 01/19/2005 | CN1185217C Propanolamine derivatives, processes for their preparation, pharmaceuticals comprising these compounds, and their use |
| 01/19/2005 | CN1185216C Fungicides |
| 01/19/2005 | CN1185213C Azetidine derivatives, preparation and pharmaceutical compositions thereof |
| 01/19/2005 | CN1184969C Use of unsubstituted and substituted N-(pyrrol-1-yl) pyridinamines as anticonvulsant agents |